Review of chromosome studies in urological tumors. II. Cytogenetics and molecular genetics of bladder cancer

Journal of Urology

Volumn 151, Issue 3, 1994, Pages 545-560

  Sandberg, A A ^a   Berger, C S ^a  

^a GENZYME CORPORATION   (United States)

Author keywords

bladder neoplasms; chromosomes; cytogenetics; genetics

Indexed keywords

BLADDER CANCER; BLADDER CARCINOGENESIS; CANCER INCIDENCE; CARCINOMA IN SITU; CHROMOSOME ABERRATION; CHROMOSOME TRANSLOCATION; CYTOGENETICS; HETEROZYGOSITY; HUMAN; HUMAN CELL; IN SITU HYBRIDIZATION; MOLECULAR GENETICS; ONCOGENE; PRIORITY JOURNAL; REVIEW; TRANSITIONAL CELL CARCINOMA; TUMOR SUPPRESSOR GENE;

EID: 0028140053     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(17)35014-0     Document Type: Article

References (128)

1. C.C. Boring T.S. Squires T. Tong Cancer statistics, 1993 CA 43 1993 7
2. W.M. Murphy Diseases of the urinary bladder, urethra, ureters, and renal pelves Urological Pathology 1989 W. B. Saunders Co. Philadelphia 34 146 chapt. 2
3. K.A. Itoku B.S. Stein Superficial bladder cancer Hematol./Oncol. Clin. N. Amer. 6 1992 99
4. A.A. Sandberg J.A. Bridge Techniques in cancer cytogenetics: an overview and update Cancer Invest. 10 1992 163
5. C. Fraser L.D. Sullivan D.K. Kalousek A routine method for cytogenetic analysis of small urinary bladder tumor biopsies Cancer Genet. Cytogenet. 29 1987 103
6. W. Smeets R. Pauwels J. Geraedts Chromosomal analysis of bladder cancer: technical aspects Cancer Genet. Cytogenet. 16 1985 259
7. J. Taillandier B. Perissel B. Giraud P. Malet Cytogenetic study of epithelial bladder cells A new technique. Cancer Genet. Cytogenet. 52 1991 246 abstract 57
8. W. Smeets R. Pauwels L. Laarakkers F. Debruyne J. Geraedts Chromosomal analysis of bladder cancer. II. A practical method Cancer Genet. Cytogenet. 29 1987 25
9. A.A. Sandberg The Chromosomes in Human Cancer and Leukemia 1980 Elsevier New York
10. A.A. Sandberg Chromosome markers and progression in bladder cancer Cancer Res. 37 1977 2950
11. A.A. Sandberg Chromosome studies in bladder cancer J.G. Connolly Carcinoma of the Bladder 1981 Raven Press New York 127 141
12. A.A. Sandberg Chromosomes in urologic cancers N. Javadpour Recent Advances in Urologic Cancer 1982 Williams & Wilkins Baltimore 21 46 chapt. 2
13. A.A. Sandberg Chromosomes in bladder cancer W.W. Bonney G.R. Prout Jr. AUA Monographs. Bladder Cancer vol. 1 1982 Williams & Wilkins Baltimore 81 94 chapt. 8
14. A.A. Sandberg Karyotypic findings in bladder carcinoma P.H. Smith G.R. Prout Jr. Urology 1. Bladder Cancer 1984 Butterworths Boston 46 65 chapt. 4
15. A.A. Sandberg Chromosome changes in bladder cancer: clinical and other correlations Cancer Genet. Cytogenet. 19 1986 163
16. W.H. Falor R.M. Ward-Skinner The importance of marker chromosomes in superficial transitional cell carcinoma of the bladder: 50 patients followed up to 17 years J. Urol. 139 1988 929
17. S. Micic M. Micic J. Milasin Chromosome analysis in patients with bladder tumor Urol. Int. 43 1988 201
18. R.P.E. Pauwels R.F.M. Schapers A.W.G.B. Smeets L.E.G. Jansen F.M.J. Debruyne J.P.M. Geraedts Blood group isoantigen deletion and chromosomal abnormalities in bladder cancer J. Urol. 140 1988 959
19. F.M. Waldman P.R. Carroll R. Kerschmann M.B. Cohen F.G. Field B.H. Mayall Centromeric copy number of chromosome 7 is strongly correlated with tumor grade and labeling index in human bladder cancer Cancer Res. 51 1991 3807
20. R. Vanni R.M. Scarpa M. Nieddu E. Usai Cytogenetic investigation on 30 bladder carcinomas Cancer Genet. Cytogenet. 30 1988 35
21. J. Milasin M. Micic S. Micic V. Diklic Distribution of marker chromosomes in relation to histologic grade in bladder cancer Cancer Genet. Cytogenet. 42 1989 135
22. N.B. Atkin M.C. Baker Cytogenetic study of ten carcinomas of the bladder: involvement of chromosomes 1 and 11 Cancer Genet. Cytogenet. 15 1985 253
23. Z. Gibas G.R. Prout J.E. Pontes J.G. Connolly A.A. Sandberg A possible specific chromosome change in transitional cell carcinoma of the bladder Cancer Genet. Cytogenet. 19 1986 229
24. R. Vanni R.M. Scarpa M. Nieddu E. Usai Identification of marker chromosomes in bladder tumor Urol. Int. 41 1986 403
25. W. Smeets R. Pauwels L. Laarakkers F. Debruyne J. Geraedts Chromosomal analysis of bladder cancer. III. Non-random alterations Cancer Genet. Cytogenet. 29 1987 29
26. Z. Gibas G.R. Prout Jr. J.G. Conolly J.E. Pontes A.A. Sandberg Nonrandom chromosomal changes in transitional cell carcinoma of the bladder Cancer Res. 44 1984 1257
27. G. Kovacs Serial cytogenetic analysis in a patient with pseudodiploid bladder cancer J. Cancer Res. Clin. Oncol. 110 1985 249
28. V.R. Babu M.D. Lutz B.J. Miles R.N. Farah L. Weiss D.L. Van Dyke Tumor behavior in transitional cell carcinoma of the bladder in relation to chromosomal markers and histopathology Cancer Res. 47 1987 6800
29. N.B. Atkin M.F. Fox 5q deletion. The sole chromosome change in a carcinoma of the bladder Cancer Genet. Cytogenet. 46 1991 129
30. Z. Gibas C.A. Griffin B.S. Emanuel Trisomy 7 and i(5p) in a transitional cell carcinoma of the ureter Letter to the Editor. Cancer Genet. Cytogenet. 25 1987 369
31. N.B. Atkin M.C. Baker Numerical chromosome changes in 165 malignant tumors Evidence for a nonrandom distribution of normal chromosomes. Cancer Genet. Cytogenet. 52 1991 113
32. A.A. Sandberg C.S. Berger F.S. Haddad D. Kerr F. Hecht Chromosome change in transitional cell carcinoma of ureter Cancer Genet. Cytogenet. 19 1986 335
33. J.M. Trent T. Stanisic S. Olson Cytogenetic analysis of urologic malignancies: study of tumor colony forming cells and premature chromosome condensation J. Urol. 131 1984 146
34. L. Granberg-Öhman B. Tribukait H. Wijkström Cytogenetic analysis of 62 transitional cell bladder carcinomas Cancer Genet. Cytogenet. 11 1984 69
35. C.S. Berger A.A. Sandberg I.A.D. Todd R.D. Pennington F.S. Haddad B.K. Hecht F. Hecht Chromosomes in kidney, ureter, and bladder cancer Cancer Genet. Cytogenet. 23 1986 1
36. R.P.E. Pauwels A.W.G.B. Smeets R.F.M. Schapers J.P.M. Geraedts F.M.J. Debruyne Grading in superficial bladder cancer. (2). Cytogenetic classification. Brit J. Urol. 61 1988 135
37. R. Vanni R.M. Scarpa Nonrandom chromosomal changes in transitional cell carcinoma of the bladder. Letter to the Editor Cancer Res. 46 1986 4873
38. R.P. Pauwels W.W. Smeets J.P. Geraedts F.M. Debruyne Cytogenetic analysis in urothelial cell carcinoma J. Urol. 137 1987 210
39. Bernues, M., Casadevall, C., Miro, R., Caballin, M. R., Gelabert, A. and Egozcue, J.: Intertitial del(9) (qllq21.2) in a case of transitional cell carcinoma of the bladder. Cancer Genet. Cytogenet., in press.
40. M.A. Knowles J.P. Cairns M.P. Williamson A.J. Proctor L.M. Coombs M.E. Eydmann Identification of multiple molecular genetic alterations in bladder cancer Cancer Genet. Cytogenet. 63 1992 140 abstract
41. S.P. Lerner Y.C. Tsai A.F. Olumi P. Nichols D.G. Skinner P.A. Jones Restriction fragment length polymorphism analysis of chromosome 9 implicates a common deleted region in human bladder cancer J. Urol. 147 part 2 1992 338A abstract 502
42. A.J. Proctor L.M. Coombs J.P. Cairns M.A. Knowles Amplification at chromosome llql3 in transitional cell tumours of the bladder Oncogene 6 1991 789
43. L. Matturri A.M. Lavezzi Recurrent chromosome alterations in transitional cell bladder carcinomas Eur. J. Histochem 36 1992 177
44. E.P. Reddy R.K. Reynolds E. Santos M. Barbacid A point mutation is responsible for the acquisition of transforming properties by the T24 human bladder carcinoma oncogene Nature 300 1982 149
45. V.R. Babu B.J. Miles J.C. Cerney L. Weiss D.L. van Dyke Chromosome 21q22 deletion. A specific chromosome change in a new bladder cancer subgroup. Letter to the Editor Cancer Genet. Cytogenet. 38 1989 127
46. P. Elfving J.C. Cigudosa R. Lundgren J. Limon N. Mandahl U. Kristoffersson S. Heim F. Mitelman Trisomy 7, trisomy 10, and loss of the Y chromosome in short-term cultures of normal kidney tissue Cytogenet. Cell Genet. 53 1990 123
47. G. Kovacs P. Brusa Clonal chromosome aberrations in normal kidney tissue from patients with renal cell carcinoma. Letter to the Editor Cancer Genet. Cytogenet. 37 1989 289
48. P. Dal Cin M.S. Aly J. Delabie J.L. Ceuppens S. Van Gool B. Van Damme L. Baert H. Van Poppel H. Van den Berghe Trisomy 7 and trisomy 10 characterize subpopulations of tumor-infiltrating lymphocytes in kidney tumors and in the surrounding kidney tissue PNAS 89 1992 9744
49. S. Heim N. Mandahl Y. Jin S. Strömblad E. Lindström L.G. Salford F. Mitelman Trisomy 7 and sex chromosome loss in human brain tissue Cancer Genet. Cytogenet. 52 1989 136
50. G. Bardi B. Johansson N. Pandis S. Heim N. Mandahl A. Andrén-Sandberg I. Hägerstrand F. Mitelman Trisomy 7 in short-term cultures of colorectal adenocarcinomas Genes Chrom. Cancer 3 1991 149
51. J.S. Lee S. Pathak V. Hopwood B. Tomasovic T.D. Mullins F.L. Baker G. Spitzer J.A. Neidhart Involvement of chromosome 7 in primary lung tumor and nonmalignant normal lung tissue Cancer Res. 47 1987 6349
52. I. Powell M. Tyrkus E. Kleer Apparent correlation of sex chromosome loss and disease course in urothelial cancer Cancer Genet. Cytogenet. 50 1990 97
53. N. Moriyama-Gonda H. Sumi H. Shiina Y. Himeno T. Ishibe Unstable chromosome aberrations in bladder and renal cell carcinoma Cancer Genet. Cytogenet. 56 1991 65
54. M. Tyrkus I. Powell W. Fakr Cytogenetic studies of carcinoma in situ of the bladder: prognostic implications J. Urol. 148 1992 44
55. A.H.N. Hopman P.J. Poddighe A.W.G.B. Smeets O. Moesker J.L.M. Beck G.P. Vooijs F.C.S. Ramaekers Detection of numerical chromosome aberrations in bladder cancer by in situ hybridization Amer. J. Path. 135 1989 1105
56. A.H.N. Hopman J. Wiegant A.K. Raap J.E. Landegent M. van der Ploeg P. van Duijn Bi-color detection of two target DNAs by non-radioactive in situ hybridization Histochemistry 85 1986 1
57. A.H.N. Hopman F.C.S. Ramaekers A.K. Raap J.L.M. Beck P. Devlee M. van der Ploeg G.P. Vooijs In situ hybridization as a tool to study numerical chromosome aberrations in solid bladder tumors Histochemistry 89 1988 307
58. A.H.N. Hopman P. Poddighe M. Vallinga A.W.G.B. Smeets F.C.S. Ramaekers Interphase cytogenetics in the analysis of chromosome aberrations correlated with bladder cancer progression Cancer Genet. Cytogenet. 63 1992 145 abstract
59. A.H.N. Hopman E. van Hooren C.A. van de Kaa P.G.P. Vooijs F.C.S. Ramaekers Detection of numerical chromosome aberrations using in situ hybridization in paraffin sections of routinely processed bladder cancers Mod. Path. 4 1991 503
60. A.H.N. Hopman O. Moesker A.W.G.B. Smeets R.P.E. Pauwels G.P. Vooijs F.C.S. Ramaekers Numerical chromosome 1, 7, 9, and 11 aberrations in bladder cancer detected by in situ hybridization Cancer Res. 51 1991 644
61. P.J. Poddighe F.C.S. Ramaekers A.W. Smeets G.P. Vooijs A.H.N. Hopman Structural chromosome 1 aberrations in transitional cell carcinoma of the bladder: interphase cytogenetics combining a centromeric, telomeric, and library DNA probe Cancer Res. 52 1992 4929
62. G. Berrozpe R. Miró M.R. Caballin J. Salvador J. Egozcue Trisomy 7 may be a primary change in noninvasive transitional cell carcinoma of the bladder Cancer Genet. Cytogenet. 50 1990 9
63. D. Perucca P. Szepetowski M.-P. Simon P. Gaudray Molecular genetics of human bladder carcinomas Cancer Genet. Cytogenet. 49 1990 143
64. Y. Nagata M. Abe K. Kobayashi S. Saiki T. Kotake K. Yoshikawa R. Ueda E. Nakayama H. Shiku Point mutations of c-ras genes in human bladder cancer and kidney cancer Jap. J. Cancer Res. 81 1990 22
65. D. Theodorescu I. Cornil B.J. Fernandez R.S. Kerbel Overexpression of normal and mutated forms of HRAS induces orthotopic bladder invasion in a human transitional cell carcinoma Proc. Natl. Acad. Sci. 87 1990 9047
66. M. Moriyama Y. Morishita S. Mori T. Akiyama T. Kato Ultrastructural localization of c-erbB-2 gene product in transitional cell carcinoma of the urinary tract Ultrastruet. Path. 14 1990 399
67. A. McCann P.A. Dervan P.A. Johnston W.J. Gullick D.N. Carney c-erbB-2 oncoprotein expression in primary human tumors Cancer 65 1990 88
68. S.-Q. Wu B.E. Storer E.A. Bookland A.J. Klingelhutz K.W. Gilchrist L.F. Meisner R. Oyasu C.A. Reznikoff Nonrandom chromosome losses in stepwise neoplastic transformation in vitro of human uroepithelial cells Cancer Res. 51 1991 3323
69. C. Kao S.-Q. Wu M. Bhattacharya L.F. Meisner C.A. Reznikoff Losses of 3p, lip and 13q in EJ/rastransformable simian virus 40-immortalized human uroepithelial cells Genes Chrom. Cancer 4 1992 158
70. A.F. Olumi Y.C. Tsai P.W. Nichols D.G. Skinner D.R. Cain L.I. Bender R.A. Jones Allelic loss of chromosome 17p distinguishes high grade from low grade transitional cell carcinomas of the bladder Cancer Res. 50 1990 7081
71. T.C. Tsai P.W. Nichols A.L. Hiti Z. Williams D.G. Skinner P.A. Jones Allelic loss of chromosomes 9, 11, and 17 in human bladder cancer Cancer Res. 50 1990 44
72. T. Habuchi O. Ogawa Y. Kakehi K. Ogura M. Koshiba T. Sugiyama O. Yoshida Allelic loss of chromosome 17p in urothelial cancer: strong association with invasive phenotype J. Urol. 148 1992 1595
73. P.K. Lipponen Over-expression of p53 nuclear oncoprotein in transitional-cell bladder cancer and its prognostic value Int. J. Cancer. 53 1993 365
74. M. Moriyama T. Akiyama T. Yamamoto T. Kawamoto T. Kato K. Sato T. Watanuki T. Hikage N. Katsuta S. Mori Expression of C-erbB-2 gene product in urinary bladder cancer J. Urol. 145 1991 423
75. L.M. Coombs D.A. Pigott E. Sweeney A.S. Proctor M.E. Eydmann C. Parkinson M.A. Knowles Amplification and over-expression of c-erbB-2 in transitional cell carcinoma of the urinary bladder Brit. J. Cancer 63 1991 601
76. C. Wright K. Mellon D.E. Neal P. Johnston I.P. Corbett C.H.W. Horne Expression of c-erbB-2 protein product in bladder cancer Brit. J. Cancer 62 1990 764
77. J.V. Harney M. Liebert G. Wedemeyer R. Washington J. Stein D. Buchsbaum Z. Steplewski H.B. Grossman The expression of epidermal growth factor receptor on human bladder cancer: potential use in radioimmunoscintigraphy J. Urol. 146 1991 227
78. D.P. Wood Jr. D.D. Wartinger V. Reuter C. Cordon-Cardo W.R. Fair R.S.K. Chaganti DNA, RNA and immuno-histochemical characterization of the HER-2/neu oncogene in transitional cell carcinoma of the bladder J. Urol. 146 1991 1398
79. D.P. Wood Jr. W.R. Fair R.S.K. Chaganti Evaluation of epidermal growth factor receptor DNA amplification and mRNA expression in bladder cancer J. Urol. 147 1992 274
80. H.B. Grossman J.V. Harney M. Liebert The expression of epidermal growth factor receptor and c-erbB-2 in high stage bladder cancer J. Urol. 147 part 2 1992 339A abstract 508
81. K. Sato M. Moriyama S. Mori M. Saito T. Watanuki K. Terada E. Okuhara T. Akiyama K. Toyoshima T. Yamamoto T. Kato An immunohistologic evaluation of c-erbB-2 gene product in patients with urinary bladder carcinoma Cancer 70 1991 2493
82. E.M. Messing Clinical implications of the expression of epidermal growth factor receptors in human transitional cell carcinoma Cancer Res. 50 1990 2530
83. E.M. Messing C.A. Reznikoff Epidermal growth factor and its receptor: markers of—and targets for—chemoprevention of bladder cancer J. Cell Biochem. 61 suppl. 1 1992 56
84. H. Gregory Isolation and structure of urogastrone and its relationship to epidermal growth factor Nature 257 1975 325
85. E.M. Messing P. Hanson P. Ulrich E. Erturk Epidermal growth factor—interactions with normal and malignant urothelium: in vivo and in situ studies J. Urol. 138 1987 1329
86. M.S. Berger C. Greenfield W.J. Gullick J. Haley J. Downward D.E. Neal A.L. Harris M.D. Waterfield Evaluation of epidermal growth factor receptors in bladder tumours Brit. J. Cancer 56 1987 533
87. D.E. Neal L. Sharpies K. Smith J. Fennelly R.R. Hall A.L. Harris The epidermal growth factor receptor and the prognosis of bladder cancer Cancer 65 1990 1619
88. K. Smith J.A. Fennelly D.E. Neal R.R. Hall A.L. Harris Characterization and quantitation of the epidermal growth factor receptor in invasive and superficial bladder tumors Cancer Res. 49 1989 5810
89. D. Livingston E. Mihich Third annual Pezcoller symposium: tumor suppressor genes Cancer Res. 52 1992 3246
90. D. Sidransky A.V. Eschenbach Y.C. Tsai P. Jones L. Summerhayes F. Marshall M. Paul P. Green S.R. Hamilton P. Frost B. Vogelstein Identification of p53 gene mutations in bladder cancers and urine samples Science 252 1991 706
91. G. Dalbagni J.C. Presti Jr. V.E. Reuter W.R. Fair C. Cordon-Cardo The role of chromosome 17 in bladder cancer J. Urol. 147 part 2 1992 338A abstract 503
92. T. Habuchi O. Ogawa Y. Kakehi T. Sugiyama O. Yoshida Allelic loss of chromosome 17p is strongly associated with invasive urothelial cancer J. Urol. 147 part 2 1992 339A abstract 505
93. J.D. Seigne S.H. Dayton D.S. Zhang D. Sgroi P.P. Griffin C.-W. Lin W.U. Shipley N.M. Heney W.S. McDougal D.W. Yandell The p53 tumor suppressor gene as a potential prognostic marker in invasive bladder cancer J. Urol. 147 part 2 1992 338A abstract 504
94. K. Fujimoto Y. Yamada E. Okajima T. Kakizoe H. Sasaki T. Sugimura M. Terada Frequent association of p53 gene mutation in invasive bladder cancer Cancer Res. 52 1992 1393
95. C.H. Spruck III W.M. Rideout III A.F. Olumi P.F. Ohneseit A.S. Yang Y.C. Tsai P.W. Nichols T. Horn G.G. Hermann K. Steven R.K. Ross M.C. Yu P.A. Jones Distinct pattern of p53 mutations in bladder cancer: relationship to tobacco usage Cancer Res. 53 1993 1162
96. R. Takahashi T. Hashimoto H.-J. Xu S.-X. Hu T. Matsui T. Miki H. Bigo-Marshall S.A. Aaronson W.F. Benedict The retinoblastoma gene functions as a growth and tumor suppressor in human bladder carcinoma cells Proc. Natl. Acad. ScL. 88 1991 5257
97. D.W. Goodrich Y. Chen P. Scully W.-H. Lee Expression of the retinoblastoma gene product in bladder carcinoma cells associates with a low frequency of tumor formation Cancer Res. 52 1992 1968
98. J.C. Presti Jr. V.E. Reuter T. Galan W.R. Fair C. Cordon-Cardo Molecular genetic alterations in superficial and locally advanced human bladder cancer Cancer Res. 51 1991 5405
99. P. Cairns A.J. Proctor M.A. Knowles Loss of heterozy gosity at the RB locus is frequent and correlates with muscle invasion in bladder carcinoma Oncogene 6 1991 2305
100. J. Ishikawa H.-J. Xu S.-X. Hu D.W. Yandell S. Maeda S. Kamidono W.F. Benedict R. Takahashi Inactivation of the retinoblastoma gene in human bladder and renal cell carcinomas Cancer Res. 51 1991 5736
101. B.J. Christian C. Kao S.-Q. Wu L.F. Meisner C.A. Reznikoff EJ/ras neoplastic transformation of simian virus 40-immortalized human uroepithelial cells: a rare event Cancer Res. 50 1990 4779
102. J. Fujita S.K. Srivastava M.H. Kraus J.S. Rhim S.R. Tronick S.A. Aaronson Frequency of molecular alterations affecting ras protooncogenes in human urinary tract tumors Proc. Natl. Acad. Sci. 82 1985 3849
103. K.V. Visvanathan R.D. Pocock I.C. Summerhayes Preferential and noval activation of H-ras in human bladder carcinomas Oncogene Res. 3 1988 77
104. B. Czerniak D. Deitch H. Simmons P. Etkind F. Herz L.G. Koss Ha-ras gene codon 12 mutation and DNA ploidy in urinary bladder carcinoma Brit. J. Cancer 62 1990 762
105. S.A. Burchill J. Lunec K. Mellon D.E. Neal Analysis of Ha-ras mutations in primary human bladder tumours Brit. J. Cancer 63 1991 62
106. M.A. Knowles M. Williamson Mutation of H-ras is infrequent in bladder cancer: confirmation of single-strand conformation polymorphism analysis, designed restriction fragment length polymorphisms, and direct sequencing Cancer Res. 53 1993 133
107. P. Fanning K. Bulovas K.S. Saini J.A. Libertino A.D. Joyce I.C. Summerhayes Elevated expression of pp60c-src in low grade human bladder carcinoma Cancer Res. 52 1992 1457
108. T. Uchida J.J. White Jr. H. Neuwirth DNA minisatellites demonstrate somatic DNA changes in most human bladder cancers Cytogenet. Cell Genet. 53 1990 61
109. D. Sidransky P. Frost A. Von Eschenbach R. Oyasu A.C. Preisinger B. Vogelstein Clonal origin of bladder cancer New Engl. J. Med. 326 1992 737
110. J. Lunec C. Challen C. Wright K. Mellon D.E. Neal c-erbB-2 amplification and identical p53 mutations in concomitant transitional carcinomas of renal pelvis and urinary bladder. Letter to the Editor Lancet 339 1992 439
111. B. Vogelstein E.R. Fearon S.R. Hamilton S.E. Kern A.C. Preisinger M. Leppert Y. Nakamura R. White A.M.M. Smits J.L. Bos Genetic alterations during colorectal-tumor development New Engl. J. Med. 319 1988 525
112. A.J. Klingelhutz S.-Q. Wu C.A. Reznikoff Nonrandom chromosome losses in tumorigenic revertants of hybrids between isogeneic immortal and neoplastic human uroepithelial cells Somat. Cell Molec. Genet. 17 1991 551
113. R.N. Borland C.B. Brendler W.B. Isaacs Molecular biology of bladder cancer Hematol. Oncol. Clin. N. Amer. 6 1992 31
114. J. Trapman The molecular biology of urological tumors Prostate suppl. 4 1992 159
115. S.E. Shackney C.A. Smith B.W. Miller D.R. Burholt K. Murtha H.R. Giles D.M. Ketterer A.A. Pollice Model for the genetic evolution of human solid tumors Cancer Res. 49 1989 3344
116. P.R. Malone K.V. Visvanathan B.A. Ponder R.J. Shearer I.C. Summerhayes Oncogenes and bladder cancer. Brit J. Urol. 57 1985 664
117. K. Oka J. Ishikawa J.M. Bruner R. Takahashi H. Saya Detection of loss of heterozygosity in the p53 gene in renal cell carcinoma and bladder cancer using the polymerase chain reaction Molec. Carcinogen. 4 1991 10
118. E.R. Fearon A.P. Feinberg S.H. Hamilton B. Vogelstein Loss of genes on the short arm on chromosome 11 in bladder cancer Nature 318 1985 377
119. H.E. Zhau X. Zhang A.C. von Eschenbach K. Scorsone R.J. Babaian J.Y. Ro M.C. Hung Amplification and expression of the c-erb B-2/neu proto-oncogene in human bladder cancer Mol. Carcinogen. 3 1990 254
120. A.A. Sandberg Chromosome changes in early bladder neoplasms J. Cell. Biochem. 61 suppl. 1 1992 76
121. A.M. Meloni A.M. Peier F.S. Haddad I.J. Powell A.M. Block R.P. Huben I. Todd W. Potter A.A. Sandberg A new approach in the diagnosis and follow-up of bladder cancer. FISH analysis of urine, bladder washings, and tumors Cancer Genet. Cytogenet. 71 1994 1
122. D.M. Schwalb H.W. Herr W.R. Fair The management of clinically unconfirmed positive urinary cytology J. Urol. 150 1993 1751
123. R. Shipman P. Schraml G. Colombi G. Raefle C.U. Ludwig Loss of heterozygosity on chromosome llpl3 in primary bladder carcinoma Hum. Genet. 91 1993 455
124. N. Miyao Y.C. Tsai S.P. Lerner A.F. Olumi C.H. Sprick III M. Gonzalez-Zulueta P.W. Nichols D.G. Skinner P.A. Jones Role of chromosome 9 in human bladder cancer Cancer Res. 53 1993 4066
125. A.J. Linnenbach L.B. Pressler B.A. Seng B.S. Kimmei J.E. Tomaszewski S.B. Malkowicz Characterization of chromosome 9 deletions in transitional cell carcinoma by microsatellite assay Hum. Mol. Genet. 2 1993 1407
126. J.M. Ruppert K. Tokino D. Sidransky Evidence for two bladder cancer suppressor loci on human chromosome 9 Cancer Res. 53 1993 5093
127. G. Dalbagni J. Presti V. Reuter W.R. Fair C. Cordon-Cardo Genetic alterations in bladder cancer Lancet 342 1993 469
128. U. Lönn S. Lönn U. Nylén S. Friberg B. Stenkvist Gene amplification detected in carcinoma cells from human urinary bladder washings by the polymerase chain reaction method Cancer 71 1993 3605